LAWRENCE, Mass., Aug. 6 /PRNewswire-FirstCall/ -- NxStage Medical, Inc.
(Nasdaq: NXTM), a leading manufacturer of innovative dialysis products,
today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert
Brown, Chief Financial Officer, will participate in the following schedule
of investor conferences. Where possible, a webcast of each event will be
made available at http://www.nxstage.com/ir.cfm at the time of each
Canaccord Adams Annual Global Growth Conference
InterContinental Boston Hotel
Tuesday, August 12, 2008
9:00 a.m. EDT
Thomas Weisel Partners Healthcare Conference
Four Seasons Hotel
Friday, September 5, 2008
8:35 a.m. EDT
UBS Global Life Sciences Conference
New York, NY
Grand Hyatt Hotel
Monday, September 22, 2008
Time to be determined.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.
This release contains "forward-looking statements" within the meaning
of the Privat
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved